Yahoo Finance

Acrivon Therapeutics Reports Positive Endometrial Cancer Data from Ongoing ACR-368 Registrational Intent Phase 2 Study at ESMO, Advancement of ACR-2316 into Clinic Ahead of ...

WATERTOWN, Mass., Sept. 14, 2024 (GLOBE NEWSWIRE) -- Acrivon Therapeutics, Inc. (“Acrivon” or “Acrivon Therapeutics”) (Nasdaq: ACRV), a clinical stage precision medicine company utilizing its Acrivon ...
Healio

ACR recommends triple therapy for lupus nephritis in new 2024 guidelines

Please provide your email address to receive an email when new articles are posted on . “We have very convincing evidence that starting with triple therapy yields better long-term outcomes for our ...
Yahoo Finance

Acrivon Therapeutics Announces FDA has Granted Breakthrough Device Designation for ACR-368 OncoSignature Assay for Endometrial Cancer

WATERTOWN, Mass., Feb. 05, 2025 (GLOBE NEWSWIRE) -- Acrivon Therapeutics, Inc. (“Acrivon” or “Acrivon Therapeutics”) (Nasdaq: ACRV), a clinical stage precision medicine company utilizing its Acrivon ...
MedPage Today

Need Help With Lupus Nephritis Management? ACR Has Your Back.

The American College of Rheumatology last published recommendations for managing lupus nephritis (LN) in 2012. Since then, targeted treatments including belimumab (Benlysta) and voclosporin (Lupkynis) ...